<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>CytoCares | wechat-feeds</title><link>http://MzAxNjQ3NjI4MA.favicon.privacyhide.com/favicon.ico</link><description>为您传递细胞治疗相关行业信息与技术进展，共同促进国内免疫治疗技术发展与行业繁荣。</description><managingEditor> (hellodword)</managingEditor><pubDate>Thu, 11 Mar 2021 21:16:58 +0800</pubDate><image><url>http://MzAxNjQ3NjI4MA.favicon.privacyhide.com/favicon.ico</url><title>CytoCares | wechat-feeds</title><link>http://MzAxNjQ3NjI4MA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>抗体药物动态-20210311</title><link>https://mp.weixin.qq.com/s/Wow7ARrzj7pib1t4OlQhzg</link><description></description><content:encoded><![CDATA[抗体药物动态-20210311]]></content:encoded><pubDate>Thu, 11 Mar 2021 18:45:37 +0800</pubDate></item><item><title>Roche等开发SAR-T：2+1双抗作为活性和安全开关</title><link>https://mp.weixin.qq.com/s/RB5C3rPDhwVt7PaoGqii2w</link><description></description><content:encoded><![CDATA[Roche等开发SAR-T：2+1双抗作为活性和安全开关]]></content:encoded><pubDate>Wed, 10 Mar 2021 18:43:55 +0800</pubDate></item><item><title>抗体药物动态-20210310</title><link>https://mp.weixin.qq.com/s/DW6Sda_21IK4wuRK0CP3KQ</link><description></description><content:encoded><![CDATA[抗体药物动态-20210310]]></content:encoded><pubDate>Wed, 10 Mar 2021 18:43:55 +0800</pubDate></item><item><title>IL-12家族：风湿，肿瘤，功能各不同</title><link>https://mp.weixin.qq.com/s/kTyUqwB98c4t0JlLksabtA</link><description></description><content:encoded><![CDATA[IL-12家族：风湿，肿瘤，功能各不同]]></content:encoded><pubDate>Tue, 09 Mar 2021 17:58:17 +0800</pubDate></item><item><title>全能核酸酶，为生物制品规模化生产解决核酸残留困扰</title><link>https://mp.weixin.qq.com/s/0-YdJcwwvVOmg33oBbi7Jw</link><description></description><content:encoded><![CDATA[全能核酸酶，为生物制品规模化生产解决核酸残留困扰]]></content:encoded><pubDate>Mon, 08 Mar 2021 19:13:18 +0800</pubDate></item><item><title>抗体药物动态-20210308</title><link>https://mp.weixin.qq.com/s/Jnbste15LeXV5D50RUV9Kg</link><description></description><content:encoded><![CDATA[抗体药物动态-20210308]]></content:encoded><pubDate>Mon, 08 Mar 2021 19:13:18 +0800</pubDate></item><item><title>Moderna公布IL-12 mRNA肿瘤疫苗I期数据，联用Durvalumab效果可期</title><link>https://mp.weixin.qq.com/s/otdAYcav2O7EuQpMoVbV0g</link><description></description><content:encoded><![CDATA[Moderna公布IL-12 mRNA肿瘤疫苗I期数据，联用Durvalumab效果可期]]></content:encoded><pubDate>Fri, 05 Mar 2021 18:42:06 +0800</pubDate></item><item><title>类风湿性关节炎疾病进程的三个检查点</title><link>https://mp.weixin.qq.com/s/PeomC7n97tNOUyLepUOa3w</link><description></description><content:encoded><![CDATA[类风湿性关节炎疾病进程的三个检查点]]></content:encoded><pubDate>Thu, 04 Mar 2021 18:32:48 +0800</pubDate></item><item><title>抗体药物动态-20210304</title><link>https://mp.weixin.qq.com/s/yWc1h8ohYluQdtj6q1nkSg</link><description></description><content:encoded><![CDATA[抗体药物动态-20210304]]></content:encoded><pubDate>Thu, 04 Mar 2021 18:32:48 +0800</pubDate></item><item><title>CAR-T细胞治疗为什么用自己的细胞更好？《Nature》子刊最新研究给出答案</title><link>https://mp.weixin.qq.com/s/Ot2A3FcVBTjzK66KId3_ew</link><description></description><content:encoded><![CDATA[CAR-T细胞治疗为什么用自己的细胞更好？《Nature》子刊最新研究给出答案]]></content:encoded><pubDate>Wed, 03 Mar 2021 19:14:59 +0800</pubDate></item><item><title>“睡美人” CAR-T</title><link>https://mp.weixin.qq.com/s/29wpdfu_VxIo8wMls-j1-Q</link><description></description><content:encoded><![CDATA[“睡美人” CAR-T]]></content:encoded><pubDate>Tue, 02 Mar 2021 18:52:12 +0800</pubDate></item><item><title>简述非典型T细胞（NKT、MAIT、γδT）</title><link>https://mp.weixin.qq.com/s/VmKCt7BdZb566rs7y_FQhw</link><description></description><content:encoded><![CDATA[简述非典型T细胞（NKT、MAIT、γδT）]]></content:encoded><pubDate>Mon, 01 Mar 2021 17:59:20 +0800</pubDate></item><item><title>抗体药物动态-20210301</title><link>https://mp.weixin.qq.com/s/vSwTZFIEn7l5jovvzxq70A</link><description></description><content:encoded><![CDATA[抗体药物动态-20210301]]></content:encoded><pubDate>Mon, 01 Mar 2021 17:59:20 +0800</pubDate></item><item><title>4-1BB+T细胞：免疫治疗革命的主角</title><link>https://mp.weixin.qq.com/s/2zhfiibaYSQ0SnGOEGb0FA</link><description></description><content:encoded><![CDATA[4-1BB+T细胞：免疫治疗革命的主角]]></content:encoded><pubDate>Fri, 26 Feb 2021 19:20:26 +0800</pubDate></item></channel></rss>